Aakaar Medical Technologies Limited, a Mumbai-based medical aesthetic solutions company, is launching its IPO on June 20, 2025, to raise ₹27.00 crore through a 100% fresh issue of 37.50 lakh shares. This NSE SME IPO targets investors interested in the fast-growing cosmetic healthcare and aesthetic device market.

Company Overview:

The company specializes in the design, manufacture, and distribution of aesthetic and cosmetic medical products, including:

• Own Brands: Domestically made devices and products

• Imported Brands: Devices and consumables sourced from Korea, Spain, Italy, and Austria

The company caters to clinics, dermatologists, cosmetic surgeons, and wellness centers. Promoted by Dilip Ramesh Meswani (24+ years of experience) and Bindi Dilip Meswani (10+ years), Aakaar Medical brings strong domain expertise and product sourcing networks.

IPO Timeline:

IPO Details:

Grey Market Premium (GMP):

• GMP (As of June 23): ₹0

• Expected Listing Price: ₹72 (flat)

• Estimated Listing Gain: 0%

⚠️ GMP data is indicative and unofficial. It does not guarantee listing performance.

Financial Snapshot (₹ in Lakhs):

The company has more than doubled its profit and revenue in just two years, indicating strong operational growth in a niche industry.

Valuation Metrics:

📊 The IPO is moderately valued, but offers less headroom for listing gains based on current EPS and peer comparison.

Use of IPO Funds:

The proceeds from the issue will be used for:

• Working capital needs

• Business expansion

• General corporate purposes

Strengths:

✅ High double-digit growth in both revenue and PAT
✅ Strong ROE and capital efficiency metrics
✅ Experienced promoters and diverse global sourcing network
✅ Niche medical aesthetic segment with demand surge

Risks:

⚠️ Low GMP with no visible market interest at the moment
⚠️ Limited brand recall or moat in a fragmented industry
⚠️ High investor entry point due to large lot size (₹1.15L minimum)
⚠️ High dependency on imported products and exchange rates

Final Verdict:

Aakaar Medical Technologies operates in a niche and growing sector with solid revenue growth and profitability. However, GMP is flat, the IPO is fairly priced with limited short-term upside, and the large ticket size may deter many retail investors.

📌 Recommendation:
🛑 Avoid for Listing Gains
✅ May consider for long-term investment if you're bullish on the cosmetic/medical aesthetics space
🔶 Conservative investors are advised to stay away due to low GMP and high entry cost

Disclaimer

This article is for educational and informational purposes only. It does not constitute investment advice. IPO investments are subject to market risks, and the Grey Market Premium is not officially regulated. Investors are advised to consult a SEBI-registered financial advisor before investing.

The Upcoming IPOs in this week and coming weeks are Supertech EV, Valencia India, Neetu Yoshi, Abram Food, PRO FX Tech, Suntech Infra Solutions, Shri Hare-Krishna Sponge Iron, Icon Facilitators, Ace Alpha Tech, Globe Civil Projects, Sambhav Steel Tubes, Ellenbarrie Indutrial Gases, Kalpataru, HDB Financials, AJC Jewel.

The Current active IPO are  Aakaar Medical Technologies, Safe Enterprises Retail Fixtures, Mayasheel Ventures.

Start your Stock Market Journey and Apply in IPO by Opening Free Demat Account in Choice Broking FinX.

Join our Trading with CA Abhay Telegram Channel for regular Stock Market Trading and Investment Calls by CA Abhay Varn - SEBI Registered Research Analyst.